Acorda Therapeutics
ACOR
#11271
Rank
โ‚ฌ0.74 M
Marketcap
0,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.39%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -โ‚ฌ0.25 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ0.11 Billion. In 2023 the company made an earning of -โ‚ฌ0.25 Billion a decrease over its 2022 earnings that were of -โ‚ฌ4.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.25 Billion2.41%
2023 -โ‚ฌ0.25 Billion4848.63%
2022 -โ‚ฌ4.87 Million-93.25%
2021 -โ‚ฌ71.99 Million2.52%
2020 -โ‚ฌ70.22 Million-69.45%
2019 -โ‚ฌ0.23 Billion-700.62%
2018 โ‚ฌ38.27 M-118.02%
2017 -โ‚ฌ0.22 Billion805.99%
2016 -โ‚ฌ23.45 Million-173.88%
2015 โ‚ฌ31.73 M-6.58%
2014 โ‚ฌ33.96 M20.19%
2013 โ‚ฌ28.26 M18.7%
2012 โ‚ฌ23.81 M-26.54%
2011 โ‚ฌ32.41 M
2009 -โ‚ฌ74.01 Million10.65%
2008 -โ‚ฌ66.89 Million86.17%
2007 -โ‚ฌ35.93 Million68.1%
2006 -โ‚ฌ21.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ27.94 M-111.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-โ‚ฌ69.66 Million-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
โ‚ฌ39.77 M-116.07%๐Ÿ‡บ๐Ÿ‡ธ USA